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Recently, in Nature Cell Biology, Kobayashi et al. (2010) report that Akt-activated sinusoidal endothelial
cells within the bone marrow modulate the self-renewal and differentiation of hematopoietic stem cells.
This finding demonstrates a mechanistic role for endothelial cells in regulating the hematopoietic stem
and progenitor cells’ pool during homeostasis and in response to myeloablative stress.Hematopoietic homeostasis, essential
for long-term survival, is achieved by a
careful balance between self-renewal
and lineage-specific differentiation of
hematopoietic stem and progenitor cells
(HSPCs). HSPCs reside in specific bone
marrow niches, and it is their interactions
with both membrane-bound and secreted
soluble factors within these niches that
promote both hematopoietic homeo-
stasis and recovery following acute injury
to the marrow (He et al., 2009). At least
two major HSPC niches exist within the
bone marrow —the perivascular niche
and the endosteal (or bone) niche (Calvi
et al., 2003; Kiel et al., 2005; Zhang
et al., 2003). While it is still controversial
whether these niches are indeed anatom-
ically and physiologically distinct, it is
recognized that cell types specific to
each niche function to modulate HSPC
activity. Investigation of the contribution
of specific cell types to hematopoietic
maintenance, however, has been hin-
dered by a dearth of models designed
to investigate specific cell populations.
In a recent issue of Nature Cell Biology,
Kobayashi et al. (2010) describe an
in vitro coculture assay with Akt-activated
endothelial cells aswell as amousemodel
where Akt was constitutively expressed
within the endothelial cell pool. Their
results demonstrate a specific mecha-
nistic relationship between the activation
state of endothelial cells within the peri-
vascular niche and expansion of HSPCs
with long-term repopulation potential.
While it has been shown that sinusoidal
endothelial cells (SECs) play a role in
hematopoietic homeostasis and marrow
reconstitution following myeloablation,
the specific molecular pathways involved
in modulating HSC expansion and re-
newal have not been described (Butleret al., 2010; Hooper et al., 2009). This
gap in knowledge is partly due to the
difficulty in culturing primary vascular
epithelial cells ex vivo without the support
of serum and angiogenic factors, whose
presence in culture significantly affects
HSC function. To circumvent this prob-
lem, Kobayashi et al. (2010) transduced
primary human umbilical cord vein endo-
thelial cells (HUVEC) with the adenovirus
gene early region 4-encoded open
reading frame-1 (E4ORF1), which led to
constitutive Akt activation and the ability
to culture the cells long-term in the
absence of serum and other supportive
factors. Coculture of these transduced
cells with lineage-negative (Lin) HSPC
led to expansion of both Lin HSPC with
long-term repopulating potential as well
as Lin+ mature hematopoietic cells (Butler
et al., 2010).
To question whether the observed
impact of Akt activation in the support
of Lin progenitors is specific to this
signaling pathway, MAPK-activated
HUVECs were generated via transduction
with constitutively activated c-Raf. Of
interest, MAPK-activated cells displayed
a significantly reduced capacity to ex-
pand Lin HSPCs in coculture, suggest-
ing that Akt activation is significantly
more supportive for endothelial cell-medi-
ated expansion of Lin progenitors with
long-term repopulating potential. Further-
more, cells expressing both activated
Akt and MAPK displayed an intermediate
ability to support Lin expansion, sug-
gesting that the balance of these two
signaling pathways in SECs potentially
controls the balance between self-re-
newal and differentiation of HSPCs found
within the perivascular niche (Figure 1).
Of note, Lin cells expanded on Akt-acti-
vated endothelial cells displayed signifi-Cell Stem Cell 7,
STEM 824_823cantly higher long-term reconstitution
capability when engrafted into lethally
irradiated murine recipients, suggesting
that these cells had a significantly higher
self-renewal capacity than those derived
from coculture with MAPK-activated
epithelial cells.
The authors further demonstrated that
Akt-activated endothelial cells express
a distinct set of HSPC-active angiocrine
factors (FGF2, IGFBP2, Ang1, BMP4,
and DHH) and produce relatively lower
levels of HSPC inhibitory factors, while
the reverse scenario is seen in MAPK-
activated cells. Of significant interest,
exposure to only conditioned media from
Akt-activated endothelial cells was not
sufficient to support expansion of Lin
HSPC, demonstrating a need for direct
cell-to-cell contact in order to support
renewal. The results of the coculture
experiments were extended to an in vivo
transgenic mouse model, in which Akt
activation could be induced specifically
in endothelial cells. As anticipated, Akt
activation in this model increased the
number of Lin HSPC as well as the total
number of hematopoietic cells permouse,
and bone marrow from activated donors
displayed significantly greater long-term
repopulating capacity when engrafted
into lethally irradiated murine hosts.
There is significant interest in under-
standing the mechanisms that control
HSPC homeostasis within the bone
marrow, as rapid reconstitution of this
compartment is essential following mye-
loablative therapies used to treat many
malignancies, and derangement of the
normal homeostatic state leads to various
myeloproliferative disorders. The impor-
tance of the vascular niche in the mainte-
nanceand reconstitutionof hematopoiesis
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Figure 1. The Activation State of Sinusoidal Endothelial Cells
Determines the Balance between HSPC Self-Renewal and
Differentiation within the Vascular Niche
Many HSPC reside in close contact with endothelial cells that form the sinu-
soidal vasculature within the bone marrow. Kobayashi et al. (2010) demon-
strate that a balance betweenAkt andMAPK signalingwithin SECs can control
the fate of HSPCs. Akt-activated SECs promote expansion of LinHSPCswith
long-term repopulating potential, while MAPK-activated SECs promote differ-
entiation. Further studies will now be able to determine the mechanisms that
control the activation status of SECs, particularly in response to bone marrow
damage. Do other marrow niche cells, for instance osteoblasts or mesen-
chymal stem cells, modulate the activation state of SECs, creating a contin-
uous stem cell niche with reciprocal lines of communication? The models pre-
sented in this study will provide valuable insight into the nature of
hematopoietic stem cell niches.
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2010; Hooper et al., 2009;
Kwonet al., 2010). The current
study, however, provides
compelling evidence of a
mechanistic link between
HSPC expansion and the acti-
vation state of sinusoidal
endothelial cells within the
vascular niche of the bone
marrow. The results reported
by Kobayashi et al. (2010)
also suggest that the balance
of specific signaling pathways
such as Akt and MAPK within
endothelial cells may function
to control HSPChomeostasis.
The findings in this study
should propel further investi-
gations of the specific role of
endothelial cells in the hema-
topoeitic stem cell niche. The
coculture system employed
in this study may function as
a unique platform to increase
the efficiency of ex vivo ex-
pansion of HSPCs, and it will
furthermore be useful in eluci-
dating additional endothelial
cell-derived signaling mecha-nisms that contribute to propagation of
the stem cell phenotype. The in vivo
model used here, in which enforced Akt
expression in sinusoidal endothelial cells
supports the expansion of HSPC with
long-term repopulation capacity, will be
important for teasing apart the regulatory
mechanisms that modify HSPC function
within the vascular niche. Further studies
using this model should help define the
precise events at play in the in vivo
setting. For example, enforced Akt
expression in endothelial cells has pre-
viously been demonstrated to induce
a state of pathological angiogenesis
in vivo that is characterized by increased
blood vessel size and permeability (Phung
et al., 2006; Sun et al., 2005). To what
extent, then, is the increase in the HSPC
pool seen in this model dependent on an
expansion of host vascular niches or on
abnormal vasculogenesis? Does the646 Cell Stem Cell 7, December 3, 2010 ª20phenotype of endothelial cells expressing
constitutively active Akt actually reflect
that seen in physiological states such as
during the bone marrow response to
chemotherapy-induced injury? In future
experiments, it will also be instructive to
determine the impact of inducible inhibi-
tion of endothelial cell Akt signaling on
hematopoietic reconstitution following
myeloablation.
The experimental tools described in
these and other studies will now be able
to help address the activation state of
SECs in response to myeloablative
therapy and whether a particular balance
of Akt versus MAPK activation in these
niche cells is necessary for reconstitution
of the hematopoietic compartment in
response to bonemarrow insults. Further-
more, it will be necessary to elucidate the
signaling molecules and cellular interac-
tions that control the activation status of10 Elsevier Inc.
STEM 824_823SECs during times of stress
in the marrow and whether
other marrow cell types, such
as osteoblasts and/or mesen-
chymal stem cells, participate
in thecontrol ofSECactivation
status. This information will
allow for the development of
new interventions to increase
engraftment and expansion
of therapeutic stem cell trans-
plants and provide insight into
disorders of dysregulated
myeloproliferation.REFERENCES
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